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Abstract
The effect of 6.MPR on the antibody formation of rabbits challenged with bovine serum al-
bumin has been studied in comparison with that of 6.MP. Observation revealed that the antibody
formation is profoundly suppressed when the animal is treated with 6.MPR in an appropriate dose
and period in relation with the introduction of antigen. Discussion was made of the possibility of
6.MPR as a superior therapeutic agent for autoimmune diseases.
∗PMID: 4263562 [PubMed - indexed for MEDLINE] Copyright c©OKAYAMA UNIVERSITY
MEDICAL SCHOOL
Acta Merl. Okayama 25, 287-293 (1971)
IMMUNOSUPPRESSIVE EFFECT OF 6.MERCAPTOPURINE-
RIBOSIDE PART IV. STUDIES ON ANTmODY
BIOSYNTHESIS
Masana OGATA
Department of Public Health, Okayama University Medical School,
Okayama, Japan
Received for publication, July 14 1971
Alkylating agents (nitrogen mustard and cyclophosphamide), purine
antagonists (6.mercaptopurine (1), azathioprine (Imuran) and 6.thiogu-
anine), and the folic acid analog (amethopterine), are widely used as
chemoimmunosuppressive agents for the therapy of "autoimmune diseases",
e. g. progressive hepatitis and rheumatoid arthritis.
Since these agents are mostly antimetabolic and quite toxic, it is
desirable to get chemicals having less toxic side.effects and keeping a
relatively high immunosuppressive activity. In this sense, six-mercapto-
purine riboside (6.MPR), which is much less toxic, may be useful as an
immunosuppressive agent in place of 6.mercaptopurine (6-MP). REGELSON
et ai. (2) have reported that the survival rate of the patients suffering from
acute leukemia treated with 6.MPR was higher than that of those treated
with 6.MP. In animal experiment, they have also demonstrated that
6-MPR was less toxic than 6-MP, showing that the maximum tolerant
dose of 6.MPR in mice was 5 times that of 6.MP, when the agents were
administered through intraperitoneal route (2). Thus it has been elucidat.
ed that the toxicity of 6.MPR is extremely low, but it remains uncertain yet
whether 6.MPR has any immunosuppressive effect. This communication
describes that 6.MPR has a relatively high immunosuppressive effect
comparable to 6.MP demonstrating a marked suppression of antibody
production in rabbit treated with 6.MPR and challenged with bovine
serum albumin.
MATERIALS AND METHODS
Twenty-seven white New-Zealand strain rabbits weighing about 2.5 kg and
kept on stock ad libitum diet were used. All animals received intramuscular
injection of crystalline bovine serum albumin (100 mg/kg) supplemented with
equal volume of complete Freund's adjuvant (Difco). The albumin was dissolved
in saline and used as 1% solution. After the albumin injection, the animals were
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divided into 3 groups, 9 animals each respectively.
In Group 1, three animals received 6-MPR intravenously 5.4 mg/kg/day
for 13 days after the injection of serum albumin, the other three animals receiv-
ed one mole equivalent of 6-MP, 3.0 mg/kg/day for the same period, and the
remaining 3 animals were left without any treatment. All the nine animals were
challenged with the second injection of bovine serum albumin 73 days after the
first injection of albumin, 0.5 ml of 1% solution intravenously.
In Group 2, all the animals received the second challenge, 5 mg of crystal-
line bovine serum albumin solution intravenously 55 days after the first injec.
tion. Of them three animals were treated with 6-MPR for two separate periods.
In the first period 6.MPR, was given 2.7 mg/kg/day for 31 days starting from the
day of the first albumin injection and in the second period a similar treatment
for 19 days from 51st day of the first albumin injection. The other 3 animals
were treated with 6-MP, 1.5 mg/kg/day, for the same period and at the same
intervals as in the former 3 ones. The rest 3 animals were not treated with im-
munosuppressive agent and served as controls.
. In Group 3, all the 9 animals received the secon'd challenge with the albu-
min 40 days after the first injection of albumin by the same method as in Groups
1 and 2. Of these, three animals were given 6-MPR and the other 3 were given
6.MP in the same dose as in Group 2 respectively but only one period of 19
days from 37th day of the first challange with albumin. The remaining 3 animals
received no immunosuppressive agents and served as control.
Antibody was measured by the tannic acid hemoagglutination method of
STAVITSKY (3) with the blood from a marginal ear vein, and the results were
expressed as the logz of the highest serum dilution which showed a+ 1 pattern.
RESULTS
In Group 1, where the rabbits were given the immunosuppressive
agents for 13 days from the first albumin injection, only a slight suppres.
sion of antibody producitons was observed on 19th day of experiment,
but thereafter actually no immunosuppressive effect of the agents was
detected.
According to the results observed on 19th day, the suppressive effect
of 6.MPR on antibody production appeared to be a little higher than that
of 6-MP. The enhanced antibody production observed after the second
injection of antigen was not suppressed (Fig. 1).
In Group 2, 3 control animals gave a relatively low titer of antibody
on 8th day, as the primary response which reached the maximum on
29th day. Thereafter, the value of titer decreased gradually, but it
increased by the second challenge with albumin. The rabbits given 6-
MPR, showed a marked delay in immuno.response and less in intensity
of antibody titer. 6-MP also showed a similar effect, but somewhat in.
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Fig 1. Immune response of rabbits against bovine serum albumin. Some
delay and suppression in response were observed by treating the animals with 6-MP
(squares) and 6-MPR (triangles). Open circles mean the values of controls receiving
no immunosuppressive treatment. Each vertical arrow represents antigen injection.
The clear block. I S A, means the period of administration of immunosuppressive
agents. Each value depicted on the graph represents the mean of 3 animals.
Method: Three tests, Fig. I-A, I-B and l-e show the results of 3 groups dif-
fering in treatment with 6-MPR and 6-MP.
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ferior to that of 6.MPR. The antibody titer of the control animals was
found to have increased on 60th day, 4 days after the second challenge.
The rate of the increase in antibody titer again appeared to be lower in
the rabbits treated with the immunosuppressive agents compared to that
of the control. The effect of 6·MPR seemed to be more intense than that
of 6·MP (Fig. 2).
In Group 3, all the animals gave a similar value of the antibody titer
after the first injection of albumin as in the control animals in Group 2,
and the maximum value appeared on 36th day. In this group, 3 animals
were treated with 6-MPR, and other 3 with 6-MP for 19 days, from
37 to 55th experimental day. That is, the treatment of animals with
immunosuppressive agents started from 5 days before the second challenge
with antigen and terminated 13 days after the second challenge. The
remaining 3 animals received the second injection of antigen but were not
treated with the immunosuppressive agents and served .as control. The
animals treated with the immunosuppressive agents gave a marked fall in
antibody titer and a minimized response to the second injection of the
antigen. In the case with 6.MPR it appeared to be superior to 6-MP in
immunosuppressive effect.
TABLE 1. VARIATION OF LEVEL OF ANTIBODY TITER OF THE RABBITS INJECTED WITH BOVINE
SERUM ALBUMIN MEASURED BY TANNIC ACID HEMAGGLUTINATION TECHNIC OF STAVITSKY AND
EFFECT OF 6-MPR AND 6.MP ON ANTIBODY PRODUCTION.
Group 1.
DaY"1 1st 13th 19th 24th 31st 41st 61st 75th0 +12 +18 +23 +30 +40 +60 +74
Group (+ 1)**
1 I <24 <24 24 24 24 26 26 214
Control 2 <24 <24 24 24 24 26 26 214
3 <24 <24 24 24 24 24 26 212
Average I <24 <24 24 24 24 25.3 26 213.3
1 <24 <24 <24 24 24 24 26 214
6-MPR 2 <24 <24 24 24 24 26 26 214
3 <24 <24 <24 24 24 26 26 212
Average <24 <24 21.3*** 24 24 25,3 26 213.3
1 <24 <24 24 24 24 26 26 214
6-MP 2 <24 <24 <24 24 24 26 26 214
3 <24 <24 22 24 24 24 26 212
Average <24 <24 22*** 24 24 25•3 26 213.3
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1st 8th 15th 23rd 29th 35th 45th 50th 57th 60th 69th 79th
o +7 + 14 +22 +28 +34 +44 +49 +56 +59 +6g +78
("'1 )**("'4)**(+13)**( +23)**
~~ays*
Group ~
--------=~------------------------------
Control
1
2
3
210 210 214
28 28 212
212 212 214
212
210
214
28 28
26 26
212 212
210 212 212 212
28 210 210 210
212 212 214 212
Average <24 24 210 210 213.3 212 28.7 28.7 210' 211.3 212 211.3
6-MPR
1 <24 <24 <24 <24
2 <24 <24 <24 24
3 <2t <24 <24 24
24
24
24
24
24
24
24
26
26
26
26
26
24
24
28
25
24
26
27
26
28
Average <24 <24 <24 22.7*** 24 24 25.3 26 25•3 25 27 27
6-MP
1 <24 <24 <24
2 <24 <24 <24
3 <24 <24 <24
24
26
26
26
26
24
26
26
26
26
26
26
24
26
28
28
28
26
28
26
28
28
26
28
Average <24 <24 <24
Group 3.
25.3 24.7 25.3 26 26 27.3 27.3 27.3
~ Days*1
Group~
1st 11 th 21 st 31st 36th 43rd 46th 55th 65th
o + 10 +20 +30 +35 +42 +45 +54 +64
(+ 1)** (+4)** (+13)**( ~ 23)**
Control
1 <24 28 212 212 214 212
2 <24 26 212 212 212 210
3 <24 28 212 212 216 28
212 214 212
28 210 212
212 214 28
Average <24 27.3 212 212 214 210 210.7 212.7 210.7
6-MPR
1 <24 26 26
2 <24 210 26
3 <24 26 26
216 218 26
216 216 26
216 216 27
26
28
27
28
28
28
26
210
28
Average <24 27.2 25 216 216.7 26 27 28 28
6-MP
1 <24 2t 24
2 <24 24 24
3 <24 24 24
212 216 28
212 214 26
212 212 26
28 210 210
210 210 210
28 28 28
Average <24 24 24 212 214 26.7 28.7 29.3 29.3
* The days after the first injection of antigen
** Titers inside the r:arenthesis show the days after the second injection
*** Calculated 24 below as 20
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DISCUSSION
The observations reported here have demonstrated clearly that 6-MPR
effectively suppresses the production of antibody against bovine serum
albumin in rabbit. Its immunosuppressive effect was comparable to that
of 6·MP or superior to the latter, when one mole equivalent dose of the
agents was injected intramusculary or intravenously. Such a property
of 6.MPR should be common to other animal strains and antigens, and
suggests that 6-MPR will be a useful medicament for autoimmune diseases
in man. It has been reported that 6-MP competes with hypoxanthine for
the binding to inosinic acid pyrophosphorylase and reacts with 5.phospho-
ribosyl pyrophosphate to be converted into thioinosic acid (4), which
interferes with the incorporation of purines in nucleonic acid synthesis.
Although the exact mechanism of the action of 6.MPR with respect
to antibody synthesis is not known, its suppressive effect on antibody
production will mainly be related to the suppression of general protein
formation through the suppression of RNA synthesis, as it is assumed that
6·MPR will be converted to thioinosic acid by the action of nucleoside
kinase and ATP (5).
Thus, 6.MPR would be superior to 6.MP as an immunosuppressive
agent, but it should be an agent to be used carefully considering its
serious side.effects. Therefore, it should be noted that further experiments
on toxicity of 6.MPR on various animals for long term administration are
required before 6.MPR is applied to patients as immunosuppressive me·
dicament.
SUMMARY
The effect of 6.MPR on the antibody formation of rabbits challenged
with bovine serum albumin has been studied in comparison with that of
6.MP. Observation revealed that the antibody formation is profoundly
suppressed when the animal is treated with 6.MPR in an appropriate dose
and period in relation with the introduction of antigen. Discussion was
made of the possibility of 6.MPR as a superior therapeutic agent for
autoimmune diseases.
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